Reference range of glycated hemoglobin in the diagnosis of diabetes mellitus

Ashima Badyal, Amarjeet S. Bhatia


Background: Diabetes mellitus is now affecting many in the workforce; it has major and deleterious impact on both individual and national productivity. Glycated hemoglobin (HbA1C) can be used as diagnostic test for diabetes subject to stringent quality assurance tests, while assays are standardized to a criteria aligned to the international reference values. HbA1C has now been recommended by American Diabetic Association (ADA) as a tool to diagnose diabetes. The main objective of the present research is to establish the reference range for glycated hemoglobin in healthy non-diabetic subjects in our hospital laboratory and compare it with the values reported by standard laboratories.

Methods: The study was conducted in the Department of Biochemistry, Super Specialty Hospital, Government Medical College, Jammu. Total number of subjects was 50 (25 males, 25 females), aged between 30-70 years. 2ml of venous blood was collected from antecubital vein under aseptic conditions from each individual and put in EDTA vials and the samples were estimated in fully auto-analyzer.

Results: This study has delivered different results for males and females. In males, the normal levels were 6.12± 0.76% while in females; the levels were 6.30 ± 0.62%. The overall range in males was 4.3- 7.18% while in females it was 4.7 - 7.30%.

Conclusions: The values were comparable (p>0.05) with those reported by standard laboratories, e.g. Dr. Lal Path Labs (<6%) and SRL Lab (≤5.7%). Hence, our values are suitable to be used as cut-off while interpreting the results of patients with diabetes mellitus.



Diabetes mellitus, Glycated hemoglobin, Reference range

Full Text:



Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53.

Sakaguchi Y, Shoji T, Hayashi T, Suzuki A, Shimzu M, Mitsumoto K. Hypomagnesaemia in type 2 diabetic retinopathy: a novel predictor of end stage renal disease. Diabetes Care. 2012;35:1591-7.

Euser AG, Cipolla MJ. Magnesium sulphate for the treatment of eclampsia, a brief review. Stroke 2009; 40: 1169-75.

Sacks DB. Carbohydrates. In: Burtis CA, Ashwood ER, Bruns DE, eds. Tietz textbook of clinical biochemistry and molecular diagnostics. 4th Ed. New Delhi: Elsevier; 2006:837-901.

Incani M, Sentenelli F, Lauraperra M, Porcer M, Lenz A, Cavalla M. Glycated hemoglobin for the diagnosis of diabetes and prediabetes: Diagnostic impact on obese on obese and lean subjects, and phenotypic characterization. J Diabetes Invest. 6:44-50.

Larsen ML, Horder M, Mogensen EF. Effect of long term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. N Engl J Med. 2013;62(1):41–3.

David B Sacks. Hemoglobin A1C in diabetes: panacea or pointless. Diabetes. 2013:62:41-3.

Mahajan RD, Mishra B. Using glycated hemoglobin HbA1c for the diagnosis of diabetes mellitus: an Indian perspective. Int J Biomed Res. 2011;2(2):508-12.

Agarwal N, Joshi S, Deshpande VK, Biswas DA. Correlation between glycated hemoglobin and glucose testing for Diabetes Mellitus screening. Int J Med Sci. 2013;67:149-54.

Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care. 2011;34:184-90.

David MN. International Expert Committee report on the role of A1C assay in the diagnosis of diabetes. Diabetes Care. 2009; 32:1327-34.

Executive summary: Standards of medical care in diabetes-2010. Diabetes Care 2010; 33(Suppl1):S4-10.